Tengjun Biotechnology Corp. Current Foreign Tax Expense (Benefit)
Tengjun Biotechnology Corp. reported Current Foreign Tax Expense (Benefit) of $191.81 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentForeignTaxExpenseBenefit · last filed 2023-05-15
- Tengjun Biotechnology Corp. current foreign tax expense (benefit) for the quarter ending 2023-03-31 was $191.81K, a 106.35% increase year-over-year.
- Tengjun Biotechnology Corp. current foreign tax expense (benefit) for the quarter ending 2022-12-31 was $1.45M.
- Tengjun Biotechnology Corp. current foreign tax expense (benefit) for the quarter ending 2022-09-30 was $1.27M.
- Tengjun Biotechnology Corp. current foreign tax expense (benefit) for the quarter ending 2022-06-30 was $503.23K.
- Tengjun Biotechnology Corp. current foreign tax expense (benefit) for fiscal 2022 was $3.31M.
| Period end | Current Foreign Tax Expense (Benefit) 3 month | Current Foreign Tax Expense (Benefit) 6 month | Current Foreign Tax Expense (Benefit) 6 month as first filed | Current Foreign Tax Expense (Benefit) 9 month | Current Foreign Tax Expense (Benefit) 12 month |
|---|---|---|---|---|---|
| 2023-03-31 | $191.81K 10-Q · filed 2023-05-15 | $1.64M derived: sum of 2 quarters · filed 2023-05-15 | $2.91M derived: sum of 3 quarters · filed 2023-05-15 | $3.41M derived: sum of 4 quarters · filed 2023-05-15 | |
| 2022-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $2.71M derived: sum of 2 quarters · filed 2023-04-17 | $3.22M derived: sum of 3 quarters · filed 2023-04-17 | $3.31M 10-K · filed 2023-04-17 | |
| 2022-09-30 | $1.27M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-11-14 | $1.77M derived: sum of 2 quarters · filed 2022-11-14 | $1.86M 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | $503.23K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2022-09-16 | $596.19K 10-Q/A · filed 2022-09-16 | $39.59K 10-Q · filed 2022-08-15 | ||
| 2022-03-31 | $92.95K 10-Q · filed 2023-05-15 |